Insights

The diagnostic error that starts at the bedside

Picture a routine morning round. A phlebotomist draws three tubes from the patient in bed seven. The labels were printed at the nurses' station ten minutes ago, against a request list that included two other patients. A junior colleague is asking a question. A drip alarm is sounding two beds along. The tubes go into the rack with the labels meant for them, and one of them is labelled with the wrong patient's name. By the time the samples reach the laboratory it is invisible: the analyser reads the label, the result is filed against the name on the label, and the chart updates against the wrong patient. A blood result drives almost every downstream decision in the ward: the medication prescribed, the dose adjusted, the transfusion ordered, the scan requested, the surgery brought forward or held back. When the result belongs to someone else, every one of those decisions is being made on the wrong body.

Where many laboratory errors begin

The laboratory often takes the call for an error it did not make. The European Federation of Clinical Chemistry and Laboratory Medicine has shown for two decades that the majority of laboratory errors are pre-analytic in origin – studies consistently attribute around 60 to 70 per cent of all laboratory errors to this phase. They occur in the chain of steps between the patient and the rack: requesting, preparation, identification, collection, handling and transport. The pain points are not technical, they are operational. A label printed in one place, applied somewhere else. A wristband never checked because the patient was known to the team. A handwritten correction added in good faith. Each one is small. Each one breaks the chain between patient and result.

Why the bedside is the critical control point

There are two places to intervene in the pre-analytic chain: the request and the draw. The request belongs to the order management system and the EHR, territory the laboratory does not control. The draw is different. It is the one moment at which the patient, the request and the tube are in the same place at the same time, and it is the last moment at which the identity of the specimen can be made or broken. If the label is produced anywhere other than the bedside, as is often the case in practice, against anything other than positive patient identification (PPID), the workflow is assuming a match that has not been verified. If the label is produced at the bedside, against a verified wristband, against an open request, the match is the act of printing.

Print, scan, verify – how the workflow holds

The setup is straightforward. A patient wristband carrying a UHF RFID tag, antimicrobial and readable at up to two metres without line of sight, allows a clinician to confirm identity at the bedside without disturbing a sleeping or distressed patient. A mobile printer on the round produces the specimen label only when an open request for that patient has been verified against the wristband. The AEP workflow logic that connects the two refuses to print otherwise. The label that emerges matches the patient, the tube and the request by construction. The clinician applies it before the tube leaves the bedside. The next read happens when the tube reaches the laboratory. The chain is now continuous, timestamped and queryable. Mislabelling is no longer dependent on memory or manual matching – it is actively prevented at the step where it most often occurs. In one peer-reviewed study, introducing PPID at the point of collection cut specimen labelling errors by around 40 per cent and removed a manual label-preprinting step that carried error potential in roughly one in four blood draws.

Where SATO fits in the wider lab stack

SATO supplies the bedside layer of this workflow: the RFID wristband, the mobile printer, the label and the AEP logic that holds the verify-before-print rule. What sits above and around it – the laboratory information management system that handles the request and the result, the order management system that schedules the test, the EHR that owns the patient record – belongs to specialist partners. The proposition is not a lab system replacement. It is a verified, traceable input at the point of collection. For pathology managers and clinical governance leads, this is what holds up under ISO 15189 audit, and under the root-cause analysis that follows a misidentification incident.

The hardest errors to investigate are the ones nobody saw happen. Pre-analytic misidentification is the type of case: small at the moment of occurrence, invisible afterwards, expensive when it surfaces in a result. Pathology managers and ward leads who want to close that window should start by mapping the points at which a label, a request and a patient are currently brought together by hand. To discuss how SATO Europe's bedside printing and PPID solutions fit your specimen labelling workflow, contact the SATO Europe health care team.